コンピテントセルの世界市場：市場規模・予測 - 製品別、用途別、エンドユーザー別、地域別分析、2023～2030年

世界のコンピテントセルの市場規模は、2022年に約21億米ドルに達し、2023～2030年の予測期間中に11.1%以上の健全な成長率で推移すると予測されています。

コンピテントセルとは、周囲の環境から外来DNA分子を取り込むことができるように遺伝子操作または処理された細菌細胞を指します。これらの細胞は、細胞壁の透過性を変化させたり、特定の遺伝子改変を施したりすることで、外来DNAを効率的に取り込み、取り込むことができます。コンピテントセル市場が拡大している背景には、慢性疾患の有病率の増加や、バイオサイエンス研究に基づく調査資金の増加といった要因があります。コンピテントセルは、プラスミドやウイルスベクターなどの組換えDNA分子を細胞内に導入し、目的の遺伝子をさらに操作、複製、発現させるために、形質転換やトランスフェクションなどの様々な遺伝子工学技術で広く使用されています。その結果、コンピテントセルの需要は、予測期間の2023～2030年の間に国際市場で徐々に増加しています。

慢性疾患はしばしば長期的な管理と治療を必要とするため、より効果的な新しい治療法に対する需要が高まっています。コンピテントセルは、潜在的な薬剤候補のスクリーニング、薬剤ターゲットの検証、リード化合物の最適化のために、創薬および薬剤開発プロセスで使用されます。慢性疾患をターゲットとする医薬品候補のパイプラインが増加していることが、医薬品の研究開発におけるコンピテントセルの需要を促進しています。国連の報告書によると、慢性疾患は世界の死亡者数の70％を占め、2030年には世界の疾病負担は56％になると予測されています。最も大きな成長が見込まれるのはアフリカと東地中海地域です。コンピテントセル市場を牽引するもう一つの重要な要因は、48の工学生物学研究開発プロジェクトに1,700万米ドルが増加していることです。バイオサイエンスの研究は、バイオテクノロジーや医薬品の新製品開発に貢献することが多いです。コンピテントセルは、組換えタンパク質、モノクローナル抗体、ワクチン、その他のバイオ医薬品の生産において重要な役割を果たしています。したがって、バイオサイエンス研究の資金が増加するにつれて、これらの産業におけるコンピテントセルの需要も増加します。さらに、英国研究革新（UKRI）技術使節団基金を通じて提供され、Innovate UKが管理する1,705万米ドルの資金は、48の多面的プロジェクトを支援しています。これらの試みは、民間企業、学術機関、さまざまな産業にまたがる関連組織間のパートナーシップを伴うものです。これらのプロジェクトの例としては、治療用途の赤血球の工学化、食肉生産に革命をもたらす動物幹細胞の変換、治療効果を高める創傷治療法の改良といった画期的な取り組みがあります。さらに、国立衛生研究所は2022年に450億米ドルの予算の大半を、生命を改善し、病気や障害を減らすことを目的とした研究に費やしました。NIHが資金を提供する研究は、発見と革新的な治療法を生み出し、人々がより長く健康的な生活を送ることを可能にし、イノベーションを推進する研究基盤を確立してきました。さらに、遺伝子編集技術の発展と合成生物学の拡大は、予測期間中、市場に有利な成長機会をもたらすと予想されます。しかし、コンピテントセルの高コストが、2023～2030年の予測期間を通じて市場全体の成長を阻害するものと思われます。

コンピテントセルの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、公開会社および非公開会社からの投資の増加と、同地域における先端製品の開発により、2022年の市場を独占しました。2021年12月、Pfizer Inc社はノースカロライナ州ダーラムに最先端の臨床製造施設を開設しました。この施設はPfizer Inc社のエンドツーエンドの遺伝子治療能力を強化し、ノースカロライナ州における同社の現在のプレゼンスに加わるもので、複数の施設で3,600人以上を雇用しています。ダーラムの施設は、Pfizer Inc社の遺伝子治療の研究開発および製造への継続的な投資を支援するために、拡張性のある最先端の遺伝子治療製造施設を3つ設立するために過去6年間に行われた8億米ドルのコミットメントの一部です。この地域の圧倒的な実績は、コンピテントセルの需要全体を促進すると予想されます。さらに、アジア太平洋地域は、予測期間中に最も急速に成長すると予想されています。慢性疾患の増加は、製薬産業の研究開発活動への投資を促進し、コンピテントセルの需要増加につながります。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 コンピテントセルの世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 コンピテントセルの世界市場力学

• コンピテントセル市場の影響分析（2020～2030年）
  • 市場促進要因
    • 慢性疾患の増加
    • バイオサイエンス研究に基づく研究費の増加
  • 市場の課題
    • コンピテントセルの初期投資の高さ
    • 熟練した専門家の不足
  • 市場機会
    • 遺伝子編集技術の発展
    • 合成生物学の拡大

第4章 世界のコンピテントセル市場の産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 産業専門家の視点
• アナリストの結論・提言

第5章 コンピテントセルの世界市場：製品別

• 市場スナップショット
• コンピテントセルの世界市場：製品別、実績 - ポテンシャル分析
• コンピテントセルの世界市場：製品別、推定・予測、2020～2030年
• コンピテントセル市場、サブセグメント別分析
  • 化学的コンピテントセル
  • エレクトロコンピテントセル

第6章 コンピテントセルの世界市場：用途別

• 市場スナップショット
• コンピテントセルの世界市場：用途別、実績 - ポテンシャル分析
• コンピテントセルの世界市場：用途別、推定・予測、2020～2030年
• コンピテントセル市場、サブセグメント別分析
  • クローニング
  • タンパク質発現
  • その他の用途

第7章 コンピテントセルの世界市場：エンドユーザー別

• 市場スナップショット
• コンピテントセルの世界市場：エンドユーザー別、実績 - ポテンシャル分析
• コンピテントセルの世界市場：エンドユーザー別、推定・予測、2020～2030年
• コンピテントセル市場、サブセグメント別分析
  • 学術研究機関
  • 製薬・バイオテクノロジー企業
  • 受託研究機関

第8章 コンピテントセルの世界市場：地域別分析

• 主要国
• 主要新興国
• コンピテントセル市場：地域別市場スナップショット
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他の中東・アフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Agilent Technologies Inc
  • Genescript Biotech Corporation
  • Bio-Rad Laboratories Inc
  • Merck & Co Inc
  • OriGene Technologies, Inc
  • New England Biolabs Inc
  • Illumina, Inc
  • Thermo Fisher Scientific, Inc
  • QIAGEN N.V.,
  • Zymo Research Corporation

第10章 調査プロセス

LIST OF TABLES

• TABLE 1.Global Competent Cells Market, report scope
• TABLE 2.Global Competent Cells Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3.Global Competent Cells Market estimates & forecasts by Product 2020-2030 (USD Billion)
• TABLE 4.Global Competent Cells Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 5.Global Competent Cells Market estimates & forecasts by End User 2020-2030 (USD Billion)
• TABLE 6.Global Competent Cells Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7.Global Competent Cells Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8.Global Competent Cells Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9.Global Competent Cells Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10.Global Competent Cells Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11.Global Competent Cells Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12.Global Competent Cells Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13.Global Competent Cells Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14.Global Competent Cells Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15.Global Competent Cells Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16.U.S. Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17.U.S. Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18.U.S. Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19.Canada Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20.Canada Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21.Canada Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22.UK Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23.UK Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24.UK Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25.Germany Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26.Germany Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27.Germany Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28.France Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29.France Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30.France Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31.Italy Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32.Italy Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33.Italy Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34.Spain Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35.Spain Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36.Spain Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37.RoE Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38.RoE Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39.RoE Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40.China Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41.China Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42.China Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43.India Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44.India Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45.India Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46.Japan Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47.Japan Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48.Japan Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49.South Korea Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50.South Korea Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51.South Korea Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52.Australia Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53.Australia Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54.Australia Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55.RoAPAC Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56.RoAPAC Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57.RoAPAC Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58.Brazil Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59.Brazil Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60.Brazil Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61.Mexico Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62.Mexico Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63.Mexico Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64.RoLA Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65.RoLA Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66.RoLA Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67.Saudi Arabia Competent Cells Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68.South Africa Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69.RoMEA Competent Cells Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70.List of secondary sources, used in the study of global Competent Cells Market
• TABLE 71.List of primary sources, used in the study of global Competent Cells Market
• TABLE 72.Years considered for the study
• TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Competent Cells Market, research methodology
• FIG 2.Global Competent Cells Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Competent Cells Market, key trends 2022
• FIG 5.Global Competent Cells Market, growth prospects 2023-2030
• FIG 6.Global Competent Cells Market, porters 5 force model
• FIG 7.Global Competent Cells Market, pest analysis
• FIG 8.Global Competent Cells Market, value chain analysis
• FIG 9.Global Competent Cells Market by segment, 2020 & 2030 (USD Billion)
• FIG 10.Global Competent Cells Market by segment, 2020 & 2030 (USD Billion)
• FIG 11.Global Competent Cells Market by segment, 2020 & 2030 (USD Billion)
• FIG 12.Global Competent Cells Market by segment, 2020 & 2030 (USD Billion)
• FIG 13.Global Competent Cells Market by segment, 2020 & 2030 (USD Billion)
• FIG 14.Global Competent Cells Market, regional snapshot 2020 & 2030
• FIG 15.North America Competent Cells Market 2020 & 2030 (USD Billion)
• FIG 16.Europe Competent Cells Market 2020 & 2030 (USD Billion)
• FIG 17.Asia pacific Competent Cells Market 2020 & 2030 (USD Billion)
• FIG 18.Latin America Competent Cells Market 2020 & 2030 (USD Billion)
• FIG 19.Middle East & Africa Competent Cells Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Competent Cells Market is valued approximately USD 2.1 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 11.1% over the forecast period 2023-2030. Competent Cells refer to bacterial cells that have been genetically engineered or treated to be capable of taking up foreign DNA molecules from their surrounding environment. These cells possess altered cell wall permeability or contain specific genetic modifications that enable them to efficiently uptake and incorporate exogenous DNA. The Competent Cells market is expanding because of factors such as increasing prevalence of chronic disease and rising funding for studies based on bioscience research. Competent cells are widely used in various genetic engineering techniques, such as transformation and transfection, to introduce recombinant DNA molecules, such as plasmids or viral vectors, into the cell for further manipulation, replication, or expression of desired genes. As a result, the demand of Competent Cells has progressively increased in the international market during the forecast period 2023-2030.

Chronic diseases often require long-term management and treatment, driving the demand for new and more effective therapies. Competent cells are used in drug discovery and development processes to screen for potential drug candidates, validate drug targets, and optimize lead compounds. The growing pipeline of drug candidates targeting chronic diseases fuels the demand for competent cells in pharmaceutical research and development. According to the United Nations report, chronic diseases are anticipated to account for 70% of all global fatalities, while the global disease burden will be 56% by the year 2030. The most significant growth is expected in the African and Eastern Mediterranean regions. Another important factor drives the Competent Cells market is increasing USD 17 million for 48 engineering biology R&D projects. As Bioscience research often contributes to the development of new biotechnological and pharmaceutical products. Competent cells play a crucial role in the production of recombinant proteins, monoclonal antibodies, vaccines, and other biopharmaceuticals. Therefore, as funding for bioscience research grows, so does the demand for competent cells in these industries. In addition, the funding of USD 17.05 million, provided through the UK Research and Innovation (UKRI) Technology Missions Fund and managed by Innovate UK, supports 48 multifaceted projects. These endeavors entail partnerships among private enterprises, academic institutions, and allied organizations spanning different industries. Examples of these projects include groundbreaking efforts such as engineering red blood cells for therapeutic applications, transforming animal stem cells to revolutionize meat production, and refining wound therapy methods to enhance medical treatment outcomes. In addition, the National Institutes of Health expended the majority of its USD 45 billion budget in 2022 for research aimed at improving life and reducing illness and disability. NIH-funded research has resulted in discoveries and innovative therapies, allowing people to live longer, healthier lives and establishing the research foundation that drives innovation. Moreover, increasing development of gene editing technologies and expansion of synthetic biology is anticipated to create a lucrative growth opportunity for the market over the forecast period. However, the high cost of Competent Cells is going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Competent Cells Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising investments from public and private companies and the development of advanced products in the region. In December 2021, Pfizer Inc has inaugurated cutting-edge clinical manufacturing facility in Durham, North Carolina. The facility enhances Pfizer's end-to-end gene therapy capabilities and adds to the company's current presence in North Carolina, where it employs over 3,600 people across multiple facilities. The Durham site is part of a USD 800 million commitment made over the last six years to establish three scalable, cutting-edge gene therapy manufacturing facilities to support Pfizer's ongoing investment in gene therapy research, development, and manufacture. The region's dominant performance is anticipated to propel the overall demand of Competent Cells. Furthermore, Asia Pacific is expected to grow fastest during the forecast period, owing to factors such as rising prevalence of chronic disease in the region. The rising prevalence of chronic diseases drives the pharmaceutical industry's investment in research and development activities, leading to increased demand for competent cells.

Major market player included in this report are:

• Agilent Technologies Inc
• Genescript Biotech Corporation
• Bio-Rad Laboratories Inc
• Merck & Co Inc
• OriGene Technologies, Inc
• New England Biolabs Inc
• Illumina, Inc
• Thermo Fisher Scientific, Inc
• QIAGEN N.V.,
• Zymo Research Corporation

Recent Developments in the Market:

• In April 2024, Agilent Technologies Inc, a global leader in the life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC San Diego), one of the world's top public research universities, announced a groundbreaking scientific collaboration to establish the Agilent Centre of Excellence (CoE) in Cellular Intelligence.

Global Competent Cells Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Product, Application, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product

• Chemically Competent Cells
• Electrocompetent Cells

By Application

• Cloning
• Protein Expression
• Other Applications

By End User

• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Competent Cells Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Competent Cells Market, by Product, 2020-2030 (USD Billion)
  • 1.2.3.Competent Cells Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Competent Cells Market, by End User, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Competent Cells Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Competent Cells Market Dynamics

• 3.1.Competent Cells Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing prevalence of chronic disease
    • 3.1.1.2.Rising funding for studies based on bioscience research
  • 3.1.2.Market Challenges
    • 3.1.2.1.High initial investment for competent cells
    • 3.1.2.2.Lack of skilled professionals
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Increasing development of gene editing technologies
    • 3.1.3.2.Expansion of synthetic biology

Chapter 4.Global Competent Cells Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Competent Cells Market, by Product

• 5.1.Market Snapshot
• 5.2.Global Competent Cells Market by Product, Performance - Potential Analysis
• 5.3.Global Competent Cells Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
• 5.4.Competent Cells Market, Sub Segment Analysis
  • 5.4.1.Chemically Competent Cells
  • 5.4.2.Electrocompetent Cells

Chapter 6.Global Competent Cells Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Competent Cells Market by Application, Performance - Potential Analysis
• 6.3.Global Competent Cells Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Competent Cells Market, Sub Segment Analysis
  • 6.4.1.Cloning
  • 6.4.2.Protein Expression
  • 6.4.3.Other Applications

Chapter 7.Global Competent Cells Market, by End User

• 7.1.Market Snapshot
• 7.2.Global Competent Cells Market by End User, Performance - Potential Analysis
• 7.3.Global Competent Cells Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
• 7.4.Competent Cells Market, Sub Segment Analysis
  • 7.4.1.Academic Research Institutes
  • 7.4.2.Pharmaceutical & Biotechnology Companies
  • 7.4.3.Contract Research Organizations

Chapter 8.Global Competent Cells Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Competent Cells Market, Regional Market Snapshot
• 8.4.North America Competent Cells Market
  • 8.4.1.U.S. Competent Cells Market
    • 8.4.1.1.Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Competent Cells Market
• 8.5.Europe Competent Cells Market Snapshot
  • 8.5.1.U.K. Competent Cells Market
  • 8.5.2.Germany Competent Cells Market
  • 8.5.3.France Competent Cells Market
  • 8.5.4.Spain Competent Cells Market
  • 8.5.5.Italy Competent Cells Market
  • 8.5.6.Rest of Europe Competent Cells Market
• 8.6.Asia-Pacific Competent Cells Market Snapshot
  • 8.6.1.China Competent Cells Market
  • 8.6.2.India Competent Cells Market
  • 8.6.3.Japan Competent Cells Market
  • 8.6.4.Australia Competent Cells Market
  • 8.6.5.South Korea Competent Cells Market
  • 8.6.6.Rest of Asia Pacific Competent Cells Market
• 8.7.Latin America Competent Cells Market Snapshot
  • 8.7.1.Brazil Competent Cells Market
  • 8.7.2.Mexico Competent Cells Market
• 8.8.Middle East & Africa Competent Cells Market
  • 8.8.1.Saudi Arabia Competent Cells Market
  • 8.8.2.South Africa Competent Cells Market
  • 8.8.3.Rest of Middle East & Africa Competent Cells Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.Agilent Technologies Inc
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Genescript Biotech Corporation
  • 9.3.3.Bio-Rad Laboratories Inc
  • 9.3.4.Merck & Co Inc
  • 9.3.5.OriGene Technologies, Inc
  • 9.3.6.New England Biolabs Inc
  • 9.3.7.Illumina, Inc
  • 9.3.8.Thermo Fisher Scientific, Inc
  • 9.3.9.QIAGEN N.V.,
  • 9.3.10.Zymo Research Corporation

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption